**Core Concept**
Muscular timidity, also known as rigidity, is a condition characterized by increased muscle tone, leading to stiffness and discomfort. This phenomenon is often observed in patients undergoing opioid therapy, particularly with high doses or long-term administration.

**Why the Correct Answer is Right**
Opioids exert their effects by interacting with opioid receptors in the central nervous system (CNS). The primary receptor subtype responsible for muscular timidity is the kappa opioid receptor (KOR). Activation of KOR by opioids leads to an increase in muscle tone, resulting in rigidity and discomfort. This is due to the inhibition of GABAergic neurotransmission and the activation of glutamatergic pathways in the brainstem and spinal cord.

**Why Each Wrong Option is Incorrect**
* **Option A:** Mu opioid receptors are primarily associated with analgesia, euphoria, and respiratory depression, but not directly with muscular timidity.
* **Option B:** Delta opioid receptors are involved in modulating pain perception, emotional responses, and cardiovascular function, but not specifically with the development of rigidity.
* **Option D:** Nociceptin/orphanin FQ peptide (NOP) receptors are involved in stress response, anxiety, and cardiovascular regulation, but not with the opioid-induced rigidity.

**Clinical Pearl / High-Yield Fact**
Remember that the kappa opioid receptor (KOR) is the primary target for opioids that induce muscular timidity, and its activation can lead to a range of adverse effects, including respiratory depression, hypotension, and bradycardia.

**Correct Answer: C. Kappa opioid receptor**